BHK Investment Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
BHK Investment Advisors's PFE Position: Q1 2023 in Review
BHK Investment Advisors sold out of Pfizer (PFE) in Q1 2023, closing a stake of 7,790 shares — an estimated $399K sold.
BHK Investment Advisors first reported a position in PFE in Q4 2017 and held it in 21 quarters. The position peaked at $844K in Q1 2019. 3,103 funds tracked by Wall St. Rank hold PFE as of Q1 2023.
- BHK Investment Advisors reported no remaining Pfizer position as of Q1 2023 after selling out during the quarter.
- BHK Investment Advisors sold 7,790 Pfizer shares in Q1 2023, an estimated $399K.
- BHK Investment Advisors first reported a position in Pfizer in Q4 2017 and held it in 21 quarters.
- BHK Investment Advisors's Pfizer position peaked at $844K in Q1 2019.
- 3,103 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.
Based on BHK Investment Advisors's 13F filing for Q1 2023, filed 9 May 2023.